| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |